How health insurance affects infertility treatment and birth outcomes
Official title: How Health Insurance Benefit Design Affects Infertility Treatment and Birth Outcomes
Funded at University of Michigan at Ann Arbor · NIH-11196071 · Data updated 2026-11-12
This study looks at how different health insurance plans affect choices people make about in vitro fertilization (IVF) and embryo transfers, with the goal of finding the best coverage options to help those struggling with infertility have healthy pregnancies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 21, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $692,937 |
| NIH project number | 5R01HD113625-02 |
| Project ID | NIH-11196071 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals or couples experiencing infertility who are considering or undergoing in vitro fertilization.
✕Less likely to help
Patients who are not seeking infertility treatment or who do not have access to IVF services may not benefit from this research.
What this research studies
This research investigates the impact of health insurance benefit designs on infertility treatment, particularly in vitro fertilization (IVF). It aims to understand how different insurance coverage options influence patient decisions regarding embryo transfers, which can significantly affect birth outcomes. By analyzing various IVF benefit structures, the study seeks to identify the most effective designs that promote healthy pregnancies while minimizing risks associated with multiple births. The findings could help shape future insurance policies to better support individuals facing infertility.
Why it matters
Potential benefit: If successful, this research could lead to improved health insurance policies that enhance the safety and effectiveness of infertility treatments for patients.
How similar studies have gone: Previous research has shown that well-designed insurance benefits can positively influence treatment outcomes in various medical fields, suggesting potential success for this approach in infertility treatment.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Dupree, James M — University of Michigan at Ann Arbor
- Study coordinator: Dupree, James M
Related research
Other NIH-funded projects on the same topics.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
Oral FSH receptor activator drugs to lower infertility treatment costs
A new oral drug approach aims to improve fertility treatments by using a small molecule that activates the FSH receptor, potentially making infertility care more affordable.
-
Prediction of ART outcomes for male factor infertility using single-molecule chromatin stenciling in sperm
A new test called sperm Fiber-seq is being developed to better predict how well ART will work for couples dealing with male-factor infertility.
-
TLR4 blocker for improving fertility in PCOS
A promising, already-approved drug (disulfiram) will be tested to see if it can reduce inflammation and improve ovulation in women with PCOS.
-
Innovative 3D-printed vaginal ring for progesterone delivery to support IVF pregnancies
A new 3D-printed vaginal ring delivers progesterone over 28 days for IVF patients, aiming to improve pregnancy success with fewer rings and less frequent dosing.
-
Genetics of Male Infertility: Accelerating Discovery and Clinical Impact
This grant aims to uncover the genetic causes of male infertility (azoospermia) to improve diagnosis and pave the way for personalized treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.